TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

119.08

+3.90 (3.39%)

Oct 8, 2025, 2:02 PM EDT - Market open

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
United States Lung Revenue	14.60M	15.76M	Log In	Log In	Log In	Upgrade
United States Heart Revenue	107.70M	96.66M	Log In	Log In	Log In	Upgrade
United States Liver Revenue	390.07M	309.46M	Log In	Log In	Log In	Upgrade
United States OCS Transplant Revenue	512.37M	421.88M	Log In	Log In	Log In	Upgrade
All Other Countries Lung Revenue	1.31M	1.93M	Log In	Log In	Log In	Upgrade
All Other Countries Heart Revenue	12.84M	13.20M	Log In	Log In	Log In	Upgrade
All Other Countries Liver Revenue	-	158.00K	Log In	Log In	Log In	Upgrade
All Other Countries OCS Transplant Revenue	14.70M	15.28M	Log In	Log In	Log In	Upgrade
Total OCS Transplant Revenue	526.96M	437.16M	Log In	Log In	Log In	Upgrade
Other Service Revenue	-	4.38M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-1.05B	-874.32M	Log In	Log In	Log In	Upgrade
Revenue (Total)	531.29M	441.54M	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Net Product Revenue	325.14M	273.87M	Log In	Log In	Log In	Upgrade
Service Revenue	206.15M	167.67M	Log In	Log In	Log In	Upgrade
Revenue (Total)	531.29M	441.54M	Log In	Log In	Log In	Upgrade

Updated Jul 30, 2025. Data Source: Fiscal.ai.